Drug profile · INN
bevacizumab-bvzr
ZIRABEV
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bevacizumab-bvzr (ZIRABEV) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN bevacizumab-bvzr
Brand ZIRABEV
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is bevacizumab-bvzr?
bevacizumab-bvzr (ZIRABEV) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for bevacizumab-bvzr?
ZIRABEV is a marketed brand name for bevacizumab-bvzr. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bevacizumab-bvzr?
bevacizumab-bvzr has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.